June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
High dose vitamin A (HDVA) treatment increases revascularization and reduces neovascularization in a rat model of oxygen induced retinopathy (OIR).
Author Affiliations & Notes
  • Julie A Mocko
    College of Optometry, University of Houston, Houston, Texas, United States
  • Deborah C Otteson
    College of Optometry, University of Houston, Houston, Texas, United States
  • Yanhong Wei
    Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States
  • Xanthi I Couroucli
    Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States
  • Laura J Frishman
    College of Optometry, University of Houston, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Julie Mocko, None; Deborah Otteson, None; Yanhong Wei, None; Xanthi Couroucli, None; Laura Frishman, None
  • Footnotes
    Support  NIH P30 EY 07551; NIH 5T32EY007024; 2014-2015 Ezell Fellowship
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3449. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Julie A Mocko, Deborah C Otteson, Yanhong Wei, Xanthi I Couroucli, Laura J Frishman; High dose vitamin A (HDVA) treatment increases revascularization and reduces neovascularization in a rat model of oxygen induced retinopathy (OIR).. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3449.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Postnatal hyperoxia disrupts retinal vascular development, causing subsequent retinal hypoxia, neural retinal injury, impaired function and neovascularization. This study examined age-related changes in vascular development, consequent changes in neural retinal thickness, and the impact of HDVA supplementation on these changes in a hyperoxic OIR rat model.

Methods : OIR was induced in Fisher 344 rats by exposure to 96±1% O2 from postnatal day P1 to P7, followed by a return to room air. Controls were raised in room air (AIR). All pups (n=3-5/age/group) received daily i.p. injections of either vehicle alone (VEH, corn oil, 33ml/kg), or with HDVA (10mg/kg) from P1 to P5. Vasculature in retinal flat mounts was labeled with isolectin GS-IB4. Retinal cross-sections (JB-4 embedded, 5µm) were stained with toludine blue. ImageJ and MATLAB were used to measure vascular coverage (%VC, vs. age-matched AIR), neovascularization (%NV, vs. VC), and retinal thickness (µm) for the central (C), middle (M) and peripheral (P) thirds of the retina. Statistical analysis used one-way ANOVA with post-hoc Tukey’s.

Results : HDVA did not affect retinal VC or thickness in AIR. Hyperoxia caused severe vaso-obliteration, with total VC in OIR rats at 5-8% by P7 (p<0.0001). One week post-hyperoxia (P14), total VC increased in OIR rats to 26-39% (p<0.0001), but was not significantly different at P21 (22-37%). Regionally, at P21, VC (±SEM) in middle retina was greater in HDVA+OIR (51±7%) vs. VEH+OIR (26±12%) rats (p=0.03). At P21, NV in central retina was reduced in HDVA+OIR (14±6%) vs. VEH+OIR (39±8%) rats (p=0.026). Inner retinal thickness at P21 decreased with eccentricity (C, M, P) in AIR (173, 153, 128; ±5µm), but not OIR rats. In contrast, the inner retina showed marked thinning in OIR rats at P21 at all eccentricities in avascular regions (83±3µm, p≤0.001), and to a lesser extent in central and middle retina in vascularized regions (129±4µm, p≤0.012). HDVA+OIR rats had no avascular central regions, and overall had more vascular vs. avascular regions than VEH+OIR rats. VEH+OIR rats had no vascularized peripheral regions.

Conclusions : Hyperoxia caused severe vaso-obliteration, followed by vaso-proliferation resulting in incomplete VC and severe NV; HDVA treatment increased VC and reduced NV. OIR-mediated retinal thinning was most severe in avascular retinal regions.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×